Hymenoptera venom @entity566 is a growing problem in Spain. This problem has a special relevance in areas where population is frequently exposed to hymenoptera stings, being paediatric @entity1 a high risk population. Immunotherapy with hymenoptera venom is an effective and safe treatment for these @entity1 . However, there is a lack of data on the role of this treatment on paediatric population. For this reason, from the data base of the Allergy Unit from Hospital Xeral (Lugo, Spain) which includes 560 @entity1 , have been analyzed the 21 paediatric @entity1 , all of them treated with venom immunotherapy. Eighteen @entity1 completed the treatment. The maintenance dose administered was 100 microg. Two systemic reactions (both with an Apis extract) were registered. Cutaneous test and specific IgE shown a statistical significant reduction at the end of treatment (p =.0004 and p <.0001 respectively). Seven @entity1 (33 %) suffered a spontaneous re-stung during maintenance phase or after immunotherapy was completed. In 4 @entity1 there was no @entity56 and the other 3 @entity1 suffered a mild local reaction. In conclusion, venom immunotherapy is a safe and effective treatment in paediatric @entity1 with hymenoptera venom @entity566 , being necessary to increase the experience on this specific segment of the allergic population.

Hymenoptera venom XXXX : characteristics, tolerance and efficacy of immunotherapy in the paediatric population.

@entity1 :: ('9606', 'Species') :: ['patients', 'children'] @entity566 :: ('MESH:D006967', 'Disease') :: ['allergy'] @entity56 :: ('MESH:D004342', 'Disease') :: ['allergic reaction']
@entity566 :: (MESH:D006967,Disease) :: ['allergy']
